Related Experiment Videos
Neuroleptic-induced tardive dyskinesia
1University Department of Neurology, Institute of Psychiatry, London, U.K.
Acta Psychiatrica Belgica
|September 1, 1987
Summary
Tardive dyskinesia, a persistent side effect of neuroleptic drugs, lacks effective treatments. Research suggests dopamine overactivity may cause this condition, but other neurotransmitter systems might also be involved.
Area of Science:
- Neuroscience
- Pharmacology
- Neurology
Background:
- Prolonged neuroleptic drug use can cause tardive dyskinesia.
- This condition may be persistent or permanent.
- The aging brain is more vulnerable to tardive dyskinesia.
Purpose of the Study:
- To review the current understanding of tardive dyskinesia.
- To discuss potential pathophysiological mechanisms.
- To highlight the limitations in current treatment and prevention.
Main Methods:
- Literature review of studies on neuroleptic-induced movement disorders.
- Analysis of proposed etiological factors and neurochemical alterations.
- Evaluation of existing therapeutic and preventive strategies.
Main Results:
- Tardive dyskinesia is a significant risk of long-term neuroleptic treatment.
- Current treatments for tardive dyskinesia are largely unsatisfactory.
- Preventive measures beyond limiting drug exposure are not established.
Conclusions:
- The pathophysiology may involve cerebral dopamine overactivity.
- Alterations in other neurotransmitter systems (acetylcholine, 5HT, GABA) could also play a role.
- Further research is needed to understand and treat tardive dyskinesia effectively.